Curis Lifesciences Ltd

NSE: CURIS · Pharmaceuticals & Biotechnology · 18 announcements

Share price: ₹202.00
Market cap: ₹163.3 Cr
Revenue (annual): ₹60.63 Cr
Net profit (annual): ₹6.92 Cr
P/E (TTM): 23.6×Sector 47.3×
Promoter holding: 68.03%
FII holding: 1.19%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 5 Management Change 3 Legal & Regulatory 2 Financial Results 2 Results Correction 1 Merger & Restructuring 1 Fund Raise 1 Board Meeting Outcome 1 Board Meeting Date 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

13 Aug 2026 19:01 IST NSE

Merger & Restructuring

Curis Lifesciences Merger & Restructuring Worth ₹0.05 Cr

Curis Lifesciences Limited has acquired a 49.95% stake in CUROSUN PHARMACEUTICAL NIG LTD, Nigeria, for Rs. 5 Lakhs to expand its pharmaceutical market presence.

Value: ₹0.05 Cr

Read the filing ↗